BMC Pulmonary Medicine
Scope & Guideline
Elevating the standards of pulmonary research and practice.
Introduction
Aims and Scopes
- Pulmonary Disease Research:
The journal covers a wide range of pulmonary diseases, including chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, lung cancer, and pulmonary hypertension, emphasizing both clinical and translational research. - Innovative Diagnostic Techniques:
Research focusing on novel diagnostic approaches such as imaging techniques (e.g., CT and MRI), biomarkers, and endobronchial ultrasound is prevalent, promoting advancements in early detection and monitoring of lung diseases. - Therapeutic Interventions:
The journal publishes studies on various treatment modalities including pharmacological interventions, surgical approaches, and emerging therapies such as biologics and immunotherapy, aiming to improve patient outcomes. - Public Health and Epidemiology:
There is a strong emphasis on epidemiological studies that investigate the prevalence, risk factors, and socio-economic impacts of respiratory diseases, particularly in diverse populations. - Patient-Centered Outcomes:
Research evaluating health-related quality of life, patient experiences, and adherence to treatment regimens is prioritized, reflecting a commitment to improving patient care in pulmonary medicine. - Mechanistic and Pathophysiological Studies:
The journal includes studies that explore the underlying mechanisms of pulmonary diseases, including genetic, molecular, and cellular factors contributing to disease progression.
Trending and Emerging
- Telemedicine and Remote Monitoring:
The COVID-19 pandemic has accelerated the adoption of telehealth strategies in pulmonary care, with increasing research on the effectiveness of remote monitoring and virtual rehabilitation programs for managing chronic respiratory diseases. - Personalized Medicine and Biomarkers:
There is a growing focus on personalized approaches in treatment, including the use of biomarkers for tailoring therapies in conditions like asthma and idiopathic pulmonary fibrosis, reflecting advancements in precision medicine. - Impact of Environmental Factors:
Research increasingly addresses the effects of air pollution, occupational exposures, and climate change on respiratory health, emphasizing the need for public health interventions and policy changes. - Machine Learning and Artificial Intelligence:
The integration of machine learning and AI in diagnostic and prognostic models for lung diseases is emerging as a key area of research, enhancing predictive accuracy and patient outcomes. - Multimorbidity in Pulmonary Diseases:
An increasing number of studies are addressing the intersection of pulmonary diseases with other chronic conditions, focusing on comprehensive management strategies that consider the whole patient. - Health Disparities and Access to Care:
Research investigating health disparities in respiratory diseases, particularly among underserved populations, is gaining attention, highlighting the need for equitable healthcare access.
Declining or Waning
- Traditional Smoking Cessation Studies:
Research solely focused on methods for smoking cessation has declined, as the journal shifts toward integrated approaches that consider smoking as part of a broader spectrum of pulmonary disease management. - Single-Disease Focus:
There is a noticeable reduction in studies exclusively targeting individual diseases without considering comorbidities, as the journal increasingly emphasizes the interconnectedness of various respiratory conditions. - Basic Science without Clinical Relevance:
The journal appears to be moving away from purely basic science studies that do not have direct clinical implications, prioritizing translational research that impacts patient care. - Outdated Therapeutic Approaches:
Research centered on older therapeutic modalities without new insights or comparative effectiveness has diminished, reflecting a trend towards innovative and evidence-based treatment strategies.
Similar Journals
BMJ Open Respiratory Research
Shaping the future of respiratory care with open access insights.BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.
Egyptian Journal of Chest Diseases and Tuberculosis
Empowering global collaboration for healthier lungs.The Egyptian Journal of Chest Diseases and Tuberculosis is a premier Open Access journal published by Wolters Kluwer Medknow Publications, focusing on the latest advancements in the fields of respiratory diseases, pulmonary medicine, and tuberculosis management. With an ISSN of 0422-7638 and an E-ISSN of 2090-9950, this journal aims to disseminate high-quality research, reviews, and clinical insights that advance the understanding and treatment of chest diseases. Since its transition to Open Access in 2018, the journal has garnered increased visibility, enabling researchers across the globe to contribute and access valuable content without barriers. Situated in India, the journal is dedicated to bridging the gap between clinical practice and research, emphasizing the significance of innovative therapeutic strategies and public health approaches in combating respiratory illnesses. We invite researchers, healthcare professionals, and students to engage with our publications as we continue to foster knowledge and foster collaboration within the global medical community.
RESPIRATION
Connecting Scholars to Transform Respiratory CareRESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.
Annals of the American Thoracic Society
Transforming respiratory medicine with timely and relevant contributions.Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.
Thoracic Research and Practice
Advancing Thoracic Health Through Innovative ResearchThoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.
Pulmonology
Unleashing the latest in pulmonary and respiratory medicine.Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.
Respiratory Investigation
Transforming insights into impactful respiratory solutions.Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Fostering breakthroughs in lung cellular and molecular research.AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, published by the American Physiological Society, stands as a prominent peer-reviewed journal dedicated to advancing the field of lung cellular and molecular physiology. With an impressive impact factor, the journal serves as a crucial platform for disseminating high-quality research focused on the intricate mechanisms underlying pulmonary function and disease. Established in 1989, this journal has consistently ranked within the top quartiles across various categories, including Q1 in Physiology and Pulmonary and Respiratory Medicine, highlighting its significance in the scientific community. The journal covers a wide scope of topics pertinent to cell biology and physiology, catering to the needs of researchers, professionals, and students seeking to explore and contribute to this vital area of study. Although currently not offering open access, it provides comprehensive access options for subscribers, ensuring that vital research is communicated effectively to the global scientific community. With a commitment to fostering innovation and inspiring future studies, the AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY remains an essential resource for those engaged in lung research.
Jornal Brasileiro de Pneumologia
Transforming respiratory medicine with groundbreaking discoveries.Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.
EUROPEAN RESPIRATORY JOURNAL
Transforming Respiratory Health Through ScienceThe EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.